Annex Advisory Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Annex Advisory Services's EW Position: Q3 2026 in Review
Annex Advisory Services reduced its Edwards Lifesciences (EW) stake by 27% in Q3 2026, selling an estimated $90.3K and leaving 2,692 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #356.
Annex Advisory Services first reported a position in EW in Q3 2023 and has held it in 13 quarters since. The position peaked at $464K in Q4 2025. 325 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Annex Advisory Services held 2,692 shares of Edwards Lifesciences worth $232K as of Q3 2026.
- Annex Advisory Services sold 1,016 Edwards Lifesciences shares in Q3 2026, an estimated $90.3K.
- Edwards Lifesciences made up ﹤0.01% of Annex Advisory Services's portfolio in Q3 2026, its #356 holding.
- Annex Advisory Services first reported a position in Edwards Lifesciences in Q3 2023 and has held it in 13 quarters since.
- Annex Advisory Services's Edwards Lifesciences position peaked at $464K in Q4 2025.
- 325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Annex Advisory Services's 13F filing for Q3 2026, filed 16 Oct 2026.